Edgewise Therapeutics Inc...

AI Score

XX

Unlock

22.05
-1.22 (-5.24%)
At close: Mar 31, 2025, 3:59 PM
22.16
0.52%
After-hours: Mar 31, 2025, 05:12 PM EDT

Edgewise Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 41.67M 86.1M 351.95M 280.79M 104.92M 23.65M
Short-Term Investments 428.5M 232.3M 329.95M 265.22M 24.18M n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 262K 348K 5.3M 3.53M 975K n/a
Receivables n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 5.31M 8.6M 10.1M 5.97M 551K 390K
Total Current Assets 475.48M 327M 351.95M 280.79M 129.65M 24.04M
Property-Plant & Equipment 11.07M 12.69M 9.85M 912K 516K 498K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 11.33M 13.04M 15.15M 4.44M 1.49M 498K
Total Assets 486.82M 340.04M 367.1M 285.23M 131.14M 24.54M
Account Payables 5.58M 4.03M 6.11M 3.84M 1.58M 667K
Deferred Revenue n/a n/a n/a n/a n/a n/a
Short-Term Debt 996K 980K 1.22M n/a n/a n/a
Other Current Liabilities 17.29M 11.77M 9.26M 6.68M 2.76M 465K
Total Current Liabilities 23.86M 16.77M 16.59M 10.52M 4.34M 1.13M
Long-Term Debt 3.74M 4.43M 3.8M n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a 329K n/a n/a
Total Long-Term Liabilities 3.74M 4.43M 3.8M 329K 160.21M 40.26M
Total Liabilities 27.6M 21.2M 20.39M 10.85M 164.56M 41.39M
Total Debt 4.74M 5.41M 4.41M n/a 160.21M 40.26M
Common Stock 9K 7K 6K 5K n/a n/a
Retained Earnings -378.58M -244.76M -144.6M -76.96M -34.15M -17.02M
Comprehensive Income 420K 99K -1.35M -514K n/a n/a
Shareholders Equity 459.22M 318.83M 346.72M 274.38M -33.42M -16.85M
Total Investments 428.5M 232.3M 329.95M 265.22M 24.18M n/a